[go: up one dir, main page]

AU2002347102A1 - Means for inhibition of the synthesis of viral proteins - Google Patents

Means for inhibition of the synthesis of viral proteins

Info

Publication number
AU2002347102A1
AU2002347102A1 AU2002347102A AU2002347102A AU2002347102A1 AU 2002347102 A1 AU2002347102 A1 AU 2002347102A1 AU 2002347102 A AU2002347102 A AU 2002347102A AU 2002347102 A AU2002347102 A AU 2002347102A AU 2002347102 A1 AU2002347102 A1 AU 2002347102A1
Authority
AU
Australia
Prior art keywords
inhibition
synthesis
viral proteins
viral
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002347102A
Inventor
Karsten Bruns
Ulrich Schubert
Uwe Tessmer
Hans Will
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002347102A1 publication Critical patent/AU2002347102A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002347102A 2001-10-25 2002-10-25 Means for inhibition of the synthesis of viral proteins Abandoned AU2002347102A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10153902 2001-10-25
DE10153902.9 2001-10-25
PCT/DE2002/004052 WO2003038032A2 (en) 2001-10-25 2002-10-25 Means for inhibition of the synthesis of viral proteins

Publications (1)

Publication Number Publication Date
AU2002347102A1 true AU2002347102A1 (en) 2003-05-12

Family

ID=7704423

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002347102A Abandoned AU2002347102A1 (en) 2001-10-25 2002-10-25 Means for inhibition of the synthesis of viral proteins

Country Status (4)

Country Link
EP (1) EP1439853A2 (en)
AU (1) AU2002347102A1 (en)
DE (1) DE20220744U1 (en)
WO (1) WO2003038032A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10361944A1 (en) * 2003-12-31 2005-07-28 Viromics Gmbh Agent for inhibiting virus replication by regulating protein folding

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2095926T5 (en) * 1990-11-02 2001-02-16 Novartis Ag CYCLOSPORINS
CA2248192A1 (en) * 1996-03-12 1997-09-18 Picower Institute For Medical Research Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity
US7108988B2 (en) * 2001-11-02 2006-09-19 The J. David Gladstone Institutes Methods of identifying agents for inhibiting lentivirus replication

Also Published As

Publication number Publication date
DE20220744U1 (en) 2004-05-13
WO2003038032A8 (en) 2003-08-14
EP1439853A2 (en) 2004-07-28
WO2003038032A3 (en) 2003-10-30
WO2003038032A2 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
AU2002363005A1 (en) Derivatives of uk-2a
AU2002329994A1 (en) Process for the synthesis of pyrazolopyrimidines
AU2003293363A1 (en) Process for the synthesis of bisphenol
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
AU2002300166A1 (en) Process for the Preparation of Peptides
SG120874A1 (en) Process for the preparation of peptides
AU2003260983A1 (en) Processes for the preparation of s-(-)-amlodipine
AU2002316593A1 (en) Solid phase synthesis of arylretinamides
AU2001277728A1 (en) Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof
AU2002255897A1 (en) Ensemble-based strategy for the design of protein pharmaceuticals
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
AU2002337601A1 (en) Process for the preparation of simvastatin
AU2002347102A1 (en) Means for inhibition of the synthesis of viral proteins
AU2002358085A1 (en) Process for the preparation of 4-methyl-7-aminoquinolones
AU2003224327A1 (en) Process for the synthesis of peptides
AU2002324291A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
AU2002342414A1 (en) Novel processes for the preparation of adenosine compounds and intermediates thereto
AU2002360409A1 (en) Methods and intermediates for the synthesis of azepines
AUPR255201A0 (en) Multi-launcher for sonobuoys
AU2002222316A1 (en) Process for the preparation of zafirlukast
AU2002344813A1 (en) Methods for synthesizing substituted pyrimidines
AU2002352424A1 (en) Solution-phase process for the manufacture of decapeptide
AU3515700A (en) Process for the synthesis of dihydropyridones
AU2002317699A1 (en) Improved synthesis of allofuranose
AU2002232061A1 (en) Compositions having improved bioavailability of eletriptan

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase